Paediatric Consumer Health in Brazil

Overall paediatric consumer health in Brazil is predicted to continue to register dynamic current value growth in 2024, presenting even better results than in the previous year. Despite the decline in cases of arboviruses such as dengue over the course of 2024, the demand for paediatric dipyrone has continued to rise. Dipyrone, along with paracetamol, remains one of the safest options for easing the symptoms of dengue, as it does not increase the risk of bleeding, unlike other OTC medications, s...

Euromonitor International's Paediatric Consumer Health in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.